These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30685104)

  • 21. Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events　- The Japan Morning Surge-Home Blood Pressure Study.
    Taki M; Ishiyama Y; Mizuno H; Komori T; Kono K; Hoshide S; Kario K
    Circ J; 2018 Jul; 82(8):2096-2102. PubMed ID: 29925742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
    Wayne Causey M; Singh N
    Semin Vasc Surg; 2014 Dec; 27(3-4):143-7. PubMed ID: 26073822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
    Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
    Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors associated plasma B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels].
    Chen Y; Yao CL; Shimada T
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):825-30. PubMed ID: 19102867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?
    Campbell DJ
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):442-6. PubMed ID: 18307738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-type natriuretic peptide: issues for the intensivist and pulmonologist.
    Phua J; Lim TK; Lee KH
    Crit Care Med; 2005 Sep; 33(9):2094-13. PubMed ID: 16148485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.
    van Kimmenade RR; Januzzi JL; Bakker JA; Houben AJ; Rennenberg R; Kroon AA; Crijns HJ; van Dieijen-Visser MP; de Leeuw PW; Pinto YM
    J Am Coll Cardiol; 2009 Mar; 53(10):884-90. PubMed ID: 19264247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias.
    Levine YC; Rosenberg MA; Mittleman M; Samuel M; Methachittiphan N; Link M; Josephson ME; Buxton AE
    Heart Rhythm; 2014 Jul; 11(7):1109-16. PubMed ID: 24837348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
    Mishra RK; Beatty AL; Jaganath R; Regan M; Wu AH; Whooley MA
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25053234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
    Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of brain natriuretic peptides in primary care patients with the clinical diagnosis of chronic heart failure.
    Zuber M; Cuculi F; Attenhofer Jost CH; Kipfer P; Buser P; Seifert B; Erne P
    Scand Cardiovasc J; 2009; 43(5):324-9. PubMed ID: 19247872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.
    Hunt PJ; Richards AM; Nicholls MG; Yandle TG; Doughty RN; Espiner EA
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):287-96. PubMed ID: 9373449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
    Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
    Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
    Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
    Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.